{"id":5196,"date":"2025-12-11T07:59:43","date_gmt":"2025-12-11T07:59:43","guid":{"rendered":"https:\/\/regenerated.health\/psoriasis\/"},"modified":"2026-06-25T14:07:28","modified_gmt":"2026-06-25T14:07:28","slug":"psoriasis","status":"publish","type":"post","link":"https:\/\/regenerated.com\/blog\/psoriasis\/","title":{"rendered":"Psoriasis: Types, Causes, Treatments, and What Functional Medicine Can Add"},"content":{"rendered":"<div class=\"at-a-glance\" style=\"background: linear-gradient(135deg, #f0f9ff 0%, #e8f4f8 100%); border-left: 4px solid #0ea5e9; border-radius: 12px; padding: 28px 32px; margin: 32px 0;\">\n<h2 style=\"color: #0c4a6e; margin: 0 0 16px;\">Psoriasis at a Glance<\/h2>\n<ul style=\"list-style: none; padding: 0; margin: 0;\">\n<li style=\"padding: 6px 0;\"><strong>Affects:<\/strong> ~125 million people worldwide (~3% of the global population)<\/li>\n<li style=\"padding: 6px 0;\"><strong>Type:<\/strong> Chronic, immune-mediated inflammatory skin disease<\/li>\n<li style=\"padding: 6px 0;\"><strong>Most common form:<\/strong> Plaque psoriasis (80-90% of cases)<\/li>\n<li style=\"padding: 6px 0;\"><strong>Key driver:<\/strong> Overactive T-cells accelerate skin cell turnover from ~28 days to 3-4 days<\/li>\n<li style=\"padding: 6px 0;\"><strong>Genetic link:<\/strong> Over 80 gene loci identified; 30-40% of patients have a first-degree relative with the condition<\/li>\n<li style=\"padding: 6px 0;\"><strong>Comorbidities:<\/strong> Cardiovascular disease, metabolic syndrome, psoriatic arthritis, depression<\/li>\n<li style=\"padding: 6px 0;\"><strong>Treatment options:<\/strong> Ranges from topical creams to advanced biologic therapies; functional medicine adds gut health, diet, and lifestyle strategies<\/li>\n<\/ul>\n<\/div>\n<p>Psoriasis is one of those conditions that looks like a skin problem on the surface but is really an immune system story playing out across your entire body. If you or someone you love deals with those stubborn, scaly patches, you already know this goes way beyond cosmetics. It affects confidence, sleep, relationships, and long-term health in ways most people never see.<\/p>\n<p>This guide covers everything you need to know: the different types, what actually causes flares, how doctors measure severity, the full menu of conventional treatments, and what regenerative and functional medicine approaches can add to the picture. We will also talk about the conditions that tag along with psoriasis (some of them serious) and when you need a dermatologist versus a rheumatologist.<\/p>\n<p>Let&#8217;s get into it.<\/p>\n<h2>What Is Psoriasis, Really?<\/h2>\n<p>At its core, psoriasis is an immune-mediated inflammatory disease. Your immune system, specifically certain T-cells and the cytokines they produce, sends faulty signals that speed up skin cell production. Normal skin cells take about 28 to 30 days to mature and shed. In psoriasis, that timeline compresses to just 3 to 4 days. The result? Skin cells pile up on the surface faster than your body can shed them, forming those characteristic raised, red, scaly plaques.<\/p>\n<p>But here is the part that often gets overlooked: psoriasis is a systemic disease. The same inflammatory pathways driving those skin lesions are also affecting your blood vessels, joints, metabolic function, and even your mental health. That is why modern treatment approaches increasingly look beyond the skin.<\/p>\n<h2>Types of Psoriasis<\/h2>\n<p>Not all psoriasis looks the same. The type you have shapes your treatment plan and your prognosis.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(300px, 1fr)); gap: 20px; margin: 32px 0;\">\n<div style=\"background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 24px; box-shadow: 0 1px 3px rgba(0,0,0,0.06);\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Plaque Psoriasis<\/h3>\n<p style=\"font-size: 14px; color: #64748b; margin-bottom: 8px;\">80-90% of all cases<\/p>\n<p>The most common form. Raised, red patches covered with silvery-white scales, typically on the elbows, knees, scalp, and lower back. These plaques can be itchy, painful, and prone to cracking and bleeding. Lesions are usually well-defined with clear borders.<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 24px; box-shadow: 0 1px 3px rgba(0,0,0,0.06);\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Guttate Psoriasis<\/h3>\n<p style=\"font-size: 14px; color: #64748b; margin-bottom: 8px;\">~8% of cases; most common in children and young adults<\/p>\n<p>Appears as small, dot-like, salmon-pink lesions scattered across the torso, arms, and legs. Often triggered by a streptococcal (strep) throat infection. In many cases, guttate psoriasis resolves on its own within weeks to months, though it can progress to plaque psoriasis.<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 24px; box-shadow: 0 1px 3px rgba(0,0,0,0.06);\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Inverse Psoriasis<\/h3>\n<p style=\"font-size: 14px; color: #64748b; margin-bottom: 8px;\">Common in skin folds<\/p>\n<p>Shows up as smooth, red, shiny patches in skin folds: the armpits, groin, under the breasts, and around the genitals. Unlike plaque psoriasis, it lacks the heavy scaling because moisture in these areas keeps the skin from flaking. It is easily confused with fungal infections and often occurs alongside other psoriasis types.<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 24px; box-shadow: 0 1px 3px rgba(0,0,0,0.06);\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Pustular Psoriasis<\/h3>\n<p style=\"font-size: 14px; color: #64748b; margin-bottom: 8px;\">Less common; can be localized or generalized<\/p>\n<p>Characterized by white, pus-filled blisters (these are sterile, not infected) surrounded by red skin. Localized forms typically affect the palms and soles (palmoplantar pustulosis). Generalized pustular psoriasis (von Zumbusch type) is a medical emergency with widespread pustules, fever, and systemic illness.<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 24px; box-shadow: 0 1px 3px rgba(0,0,0,0.06);\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Erythrodermic Psoriasis<\/h3>\n<p style=\"font-size: 14px; color: #64748b; margin-bottom: 8px;\">Rare (~3%); medical emergency<\/p>\n<p>The most severe form. Fiery redness covers most of the body surface, and the skin sheds in large sheets rather than small scales. This disrupts the body&#8217;s temperature regulation and fluid balance and can lead to life-threatening complications including infection, heart failure, and hypothermia. Requires immediate medical attention.<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 24px; box-shadow: 0 1px 3px rgba(0,0,0,0.06);\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Nail Psoriasis<\/h3>\n<p style=\"font-size: 14px; color: #64748b; margin-bottom: 8px;\">Affects up to 50% of psoriasis patients<\/p>\n<p>Causes pitting, discoloration (yellow-brown &#8220;oil drop&#8221; spots), thickening, crumbling, and separation of the nail from the nail bed (onycholysis). Nail involvement often signals a higher risk of developing psoriatic arthritis. Treatment can be challenging due to slow nail growth.<\/p>\n<\/div>\n<\/div>\n<h3>The Psoriatic Arthritis Connection<\/h3>\n<p>About 30% of people with psoriasis will develop psoriatic arthritis (PsA), an inflammatory joint condition that can cause permanent joint damage if left untreated. Skin symptoms typically appear first, sometimes by a decade or more, but in about 15% of cases the joint symptoms come first.<\/p>\n<div style=\"background: #fffbeb; border-left: 4px solid #f59e0b; border-radius: 8px; padding: 20px 24px; margin: 24px 0;\">\n<strong style=\"color: #92400e;\">Key Takeaway:<\/strong> If you have psoriasis and start noticing joint stiffness, swelling in your fingers or toes (&#8220;sausage digits&#8221;), heel pain, or lower back stiffness, especially in the morning, bring this up with your doctor immediately. Early treatment of psoriatic arthritis prevents irreversible joint erosion.\n<\/div>\n<h2>What Causes Psoriasis? The Immune System, Genetics, and Triggers<\/h2>\n<h3>The Immune Mechanism<\/h3>\n<p>Psoriasis is driven by a miscommunication in the immune system. Here is the simplified version of what happens:<\/p>\n<ol>\n<li><strong>Dendritic cells<\/strong> in the skin become activated (by injury, infection, stress, or other triggers).<\/li>\n<li>These cells release cytokines, particularly <strong>IL-12<\/strong> and <strong>IL-23<\/strong>, which activate T-helper cells (Th1 and Th17 cells).<\/li>\n<li>Th17 cells produce <strong>IL-17<\/strong> and <strong>IL-22<\/strong>, which tell skin cells (keratinocytes) to multiply rapidly.<\/li>\n<li>Keratinocytes respond by proliferating at an accelerated rate and producing their own inflammatory signals, creating a <strong>self-sustaining inflammatory loop<\/strong>.<\/li>\n<li><strong>TNF-alpha<\/strong> amplifies the entire process, fueling both skin inflammation and systemic effects.<\/li>\n<\/ol>\n<p>This is why modern biologic drugs target specific points in this pathway: TNF-alpha, IL-17, and IL-23. They interrupt the cycle at its source rather than broadly suppressing the immune system.<\/p>\n<h3>Genetics<\/h3>\n<p>Psoriasis has a strong genetic component. Researchers have identified over 80 gene loci associated with the disease. The most significant is <strong>PSORS1<\/strong> on chromosome 6, which accounts for about 35-50% of genetic risk. The HLA-Cw6 allele within this region is particularly important.<\/p>\n<p>If one parent has psoriasis, the child has about a 10-15% chance of developing it. If both parents are affected, that risk climbs to roughly 50%. But genetics alone do not determine your fate. Many people carry psoriasis-associated genes and never develop the disease. Something has to flip the switch.<\/p>\n<h3>Common Triggers<\/h3>\n<table style=\"width: 100%; border-collapse: collapse; margin: 24px 0; border-radius: 8px; overflow: hidden;\">\n<thead>\n<tr style=\"background: #1e3a5f; color: #ffffff;\">\n<th style=\"padding: 14px 18px; text-align: left; font-weight: 600;\">Trigger Category<\/th>\n<th style=\"padding: 14px 18px; text-align: left; font-weight: 600;\">Examples<\/th>\n<th style=\"padding: 14px 18px; text-align: left; font-weight: 600;\">Notes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Infections<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Strep throat, upper respiratory infections, HIV<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Strep is the classic trigger for guttate psoriasis<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Skin injury<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Cuts, scrapes, sunburn, tattoos, surgical wounds<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Known as the Koebner phenomenon: psoriasis appearing at injury sites<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Stress<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Emotional stress, chronic anxiety, major life events<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Stress raises cortisol and inflammatory cytokines; a known flare trigger in 40-80% of patients<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Medications<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Lithium, beta-blockers, antimalarials, rapid steroid withdrawal<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Abrupt discontinuation of systemic steroids can trigger rebound flares or pustular\/erythrodermic psoriasis<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Lifestyle factors<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Smoking, heavy alcohol use, obesity<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">All three increase systemic inflammation and worsen disease severity<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Weather and climate<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Cold, dry weather; low humidity; reduced sunlight<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Most patients experience worsening in winter and improvement in summer<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 12px 18px;\">Hormonal changes<\/td>\n<td style=\"padding: 12px 18px;\">Puberty, pregnancy, menopause<\/td>\n<td style=\"padding: 12px 18px;\">Psoriasis often improves during pregnancy (due to immune modulation) and flares postpartum<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Measuring Severity: PASI, BSA, and DLQI<\/h2>\n<p>How bad is your psoriasis? That is not just a casual question. The answer determines which treatments are appropriate, whether insurance covers biologic therapy, and how your doctor tracks your progress.<\/p>\n<h3>Body Surface Area (BSA)<\/h3>\n<p>The simplest measure. One palm (including fingers) equals about 1% of body surface area. Mild psoriasis covers less than 3% BSA, moderate covers 3-10%, and severe covers more than 10%.<\/p>\n<h3>Psoriasis Area and Severity Index (PASI)<\/h3>\n<p>The gold standard in clinical trials and dermatology offices. PASI scores range from 0 to 72 and account for the area of skin involved plus the severity of redness, thickness, and scaling across four body regions (head, trunk, upper extremities, lower extremities). A PASI score above 10 generally qualifies as moderate-to-severe disease.<\/p>\n<p>Clinical trials often report results as &#8220;PASI 75&#8221; or &#8220;PASI 90,&#8221; meaning the percentage of patients who achieved a 75% or 90% reduction in their PASI score. Newer biologics regularly achieve PASI 90 in 50-70% of patients, which would have been unthinkable 20 years ago.<\/p>\n<h3>Dermatology Life Quality Index (DLQI)<\/h3>\n<p>This 10-question survey measures how much psoriasis affects your daily life: work, relationships, clothing choices, sleep, self-consciousness. A DLQI above 10 indicates a large effect on quality of life. This matters because someone with limited BSA in a visible or sensitive area (face, hands, genitals) may suffer more than someone with larger patches on the trunk.<\/p>\n<div style=\"background: #fffbeb; border-left: 4px solid #f59e0b; border-radius: 8px; padding: 20px 24px; margin: 24px 0;\">\n<strong style=\"color: #92400e;\">Key Takeaway:<\/strong> Severity is not just about how much skin is covered. Location, impact on quality of life, and the presence of psoriatic arthritis all factor into treatment decisions. A patient with 2% BSA on the palms may qualify for biologic therapy if it significantly impairs hand function.\n<\/div>\n<h2>Conventional Treatments: The Full Toolkit<\/h2>\n<p>Treatment for psoriasis follows a stepwise approach. Your doctor will typically start with the least aggressive options and escalate based on disease severity, location, and your response.<\/p>\n<h3>Step 1: Topical Therapies<\/h3>\n<p>For mild-to-moderate psoriasis (less than 10% BSA), topicals are the first line of defense.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 24px 0; border-radius: 8px; overflow: hidden;\">\n<thead>\n<tr style=\"background: #1e3a5f; color: #ffffff;\">\n<th style=\"padding: 14px 18px; text-align: left;\">Topical Agent<\/th>\n<th style=\"padding: 14px 18px; text-align: left;\">How It Works<\/th>\n<th style=\"padding: 14px 18px; text-align: left;\">Pros<\/th>\n<th style=\"padding: 14px 18px; text-align: left;\">Cons<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\"><strong>Corticosteroids<\/strong><\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Reduce inflammation and slow cell turnover<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Fast-acting, effective, available in multiple strengths<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Skin thinning with prolonged use; rebound flares possible<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\"><strong>Vitamin D analogs<\/strong> (calcipotriene\/calcipotriol)<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Slow keratinocyte proliferation and promote normal differentiation<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Safe for long-term use; effective combined with steroids<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Slower onset; can irritate skin<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\"><strong>Calcineurin inhibitors<\/strong> (tacrolimus, pimecrolimus)<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Reduce T-cell activation locally<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Safe for sensitive areas (face, groin, skin folds)<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Burning sensation initially; off-label for psoriasis<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\"><strong>Tar preparations<\/strong><\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Anti-inflammatory and antiproliferative<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Long track record; available OTC<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Messy, strong odor, stains clothing<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 12px 18px;\"><strong>Tapinarof<\/strong> (newer)<\/td>\n<td style=\"padding: 12px 18px;\">Aryl hydrocarbon receptor agonist; modulates immune response<\/td>\n<td style=\"padding: 12px 18px;\">Steroid-free; FDA-approved 2022; durable &#8220;remittive&#8221; effect<\/td>\n<td style=\"padding: 12px 18px;\">Folliculitis in some patients; newer (less long-term data)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3>Step 2: Phototherapy<\/h3>\n<p>When topicals alone are not enough, light therapy is the next step. It works by slowing skin cell turnover and suppressing local immune activity.<\/p>\n<ul>\n<li><strong>Narrowband UVB (NB-UVB):<\/strong> The most common form. Treatments are 2-3 times weekly for 2-3 months. Effective for widespread plaque psoriasis. Can be done in-office or with an at-home unit.<\/li>\n<li><strong>Excimer laser (308 nm):<\/strong> Targets individual plaques with focused UVB light. Ideal for stubborn, localized patches.<\/li>\n<li><strong>PUVA (Psoralen + UVA):<\/strong> Patient takes a photosensitizing drug (psoralen) before UVA exposure. More effective than UVB for some cases but carries higher long-term skin cancer risk. Used less frequently today.<\/li>\n<\/ul>\n<h3>Step 3: Systemic Therapies (Non-Biologic)<\/h3>\n<p>For moderate-to-severe psoriasis that does not respond to topicals and phototherapy.<\/p>\n<ul>\n<li><strong>Methotrexate:<\/strong> A weekly oral or injectable drug that suppresses the overactive immune response. Effective for both skin and joint disease. Requires regular blood monitoring (liver, blood counts). Folic acid supplementation reduces side effects.<\/li>\n<li><strong>Cyclosporine:<\/strong> A potent immunosuppressant that works quickly. Typically limited to short-term use (3-6 months on, then off) due to kidney toxicity and blood pressure effects.<\/li>\n<li><strong>Acitretin:<\/strong> An oral retinoid. Particularly useful for pustular and erythrodermic psoriasis. Strongly teratogenic (causes birth defects); women of childbearing age must avoid pregnancy for 3 years after stopping.<\/li>\n<li><strong>Apremilast (Otezla):<\/strong> A PDE4 inhibitor taken orally. Milder efficacy compared to biologics but a favorable safety profile with no required lab monitoring. Works well for mild-to-moderate cases.<\/li>\n<li><strong>Deucravacitinib (Sotyktu):<\/strong> A newer oral TYK2 inhibitor approved in 2022. More effective than apremilast with a good safety profile. Represents a promising new oral option.<\/li>\n<\/ul>\n<h3>Step 4: Biologic Therapies<\/h3>\n<p>Biologics have transformed psoriasis care. These are injectable or infused proteins that target specific molecules in the inflammatory cascade. They are the most effective treatments available for moderate-to-severe disease.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(280px, 1fr)); gap: 20px; margin: 32px 0;\">\n<div style=\"background: #ffffff; border: 1px solid #e2e8f0; border-top: 4px solid #dc2626; border-radius: 12px; padding: 24px;\">\n<h4 style=\"color: #dc2626; margin-top: 0;\">TNF-alpha Inhibitors<\/h4>\n<p style=\"font-size: 14px; color: #64748b;\">First-generation biologics<\/p>\n<ul>\n<li><strong>Adalimumab<\/strong> (Humira and biosimilars)<\/li>\n<li><strong>Etanercept<\/strong> (Enbrel)<\/li>\n<li><strong>Infliximab<\/strong> (Remicade; IV infusion)<\/li>\n<li><strong>Certolizumab pegol<\/strong> (Cimzia)<\/li>\n<\/ul>\n<p><strong>PASI 75 rates:<\/strong> ~50-75%<br \/><strong>Key advantage:<\/strong> Long track record; also effective for psoriatic arthritis and inflammatory bowel disease<br \/><strong>Watch for:<\/strong> Increased infection risk; reactivation of latent TB; periodic screening required<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e2e8f0; border-top: 4px solid #7c3aed; border-radius: 12px; padding: 24px;\">\n<h4 style=\"color: #7c3aed; margin-top: 0;\">IL-17 Inhibitors<\/h4>\n<p style=\"font-size: 14px; color: #64748b;\">Targeting the Th17 pathway<\/p>\n<ul>\n<li><strong>Secukinumab<\/strong> (Cosentyx)<\/li>\n<li><strong>Ixekizumab<\/strong> (Taltz)<\/li>\n<li><strong>Brodalumab<\/strong> (Siliq; targets IL-17 receptor)<\/li>\n<li><strong>Bimekizumab<\/strong> (Bimzelx; dual IL-17A\/F)<\/li>\n<\/ul>\n<p><strong>PASI 90 rates:<\/strong> ~55-75%<br \/><strong>Key advantage:<\/strong> Rapid onset; very high clearance rates, especially bimekizumab<br \/><strong>Watch for:<\/strong> Increased risk of Candida (yeast) infections; avoid in patients with inflammatory bowel disease (brodalumab, especially)<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e2e8f0; border-top: 4px solid #059669; border-radius: 12px; padding: 24px;\">\n<h4 style=\"color: #059669; margin-top: 0;\">IL-23 Inhibitors<\/h4>\n<p style=\"font-size: 14px; color: #64748b;\">The newest class with impressive durability<\/p>\n<ul>\n<li><strong>Guselkumab<\/strong> (Tremfya)<\/li>\n<li><strong>Risankizumab<\/strong> (Skyrizi)<\/li>\n<li><strong>Tildrakizumab<\/strong> (Ilumya)<\/li>\n<\/ul>\n<p><strong>PASI 90 rates:<\/strong> ~60-75%<br \/><strong>Key advantage:<\/strong> Less frequent dosing (every 8-12 weeks after loading); excellent long-term durability; favorable safety profile<br \/><strong>Watch for:<\/strong> Generally well-tolerated; upper respiratory infections most common side effect<\/p>\n<\/div>\n<\/div>\n<div style=\"background: #fffbeb; border-left: 4px solid #f59e0b; border-radius: 8px; padding: 20px 24px; margin: 24px 0;\">\n<strong style=\"color: #92400e;\">Key Takeaway:<\/strong> IL-23 inhibitors like risankizumab and guselkumab are increasingly considered first-line biologics due to their high efficacy, convenient dosing (as infrequent as every 12 weeks), strong safety data, and evidence suggesting some patients maintain remission even after stopping treatment (a concept called &#8220;treatment-free remission&#8221;). This is a major shift in how we think about psoriasis management.\n<\/div>\n<h3>IL-12\/23 Inhibitor<\/h3>\n<p><strong>Ustekinumab (Stelara)<\/strong> deserves a mention as the original IL-pathway biologic. It blocks both IL-12 and IL-23 and has an excellent track record going back to 2009. Dosing is every 12 weeks, and it is effective for both psoriasis and psoriatic arthritis. While newer agents have surpassed its efficacy numbers, its safety profile is among the best studied in the biologic class.<\/p>\n<h2>Regenerative and Functional Medicine Approaches<\/h2>\n<p>Conventional treatments are highly effective, and anyone with moderate-to-severe psoriasis should be working with a dermatologist. But there is a growing body of evidence showing that certain lifestyle, dietary, and supplement strategies can reduce flare frequency, lower overall inflammation, and sometimes even reduce the amount of medication needed.<\/p>\n<p>Think of these approaches as the foundation your conventional treatment sits on. Not replacements, but force multipliers.<\/p>\n<h3>The Gut-Skin Axis<\/h3>\n<p>This is one of the most exciting areas in psoriasis research. People with psoriasis consistently show altered gut microbiome profiles compared to healthy controls. They tend to have reduced microbial diversity, lower levels of beneficial bacteria like <em>Faecalibacterium prausnitzii<\/em> and <em>Akkermansia muciniphila<\/em>, and higher intestinal permeability (&#8220;leaky gut&#8221;).<\/p>\n<p>When the gut barrier is compromised, bacterial fragments (like lipopolysaccharides) enter the bloodstream and trigger systemic immune activation, the same TNF-alpha and IL-17 pathways involved in psoriasis.<\/p>\n<p><strong>What the research suggests:<\/strong><\/p>\n<ul>\n<li>Probiotic supplementation (especially <em>Lactobacillus<\/em> and <em>Bifidobacterium<\/em> strains) has shown modest improvements in PASI scores in several small trials.<\/li>\n<li>Addressing small intestinal bacterial overgrowth (SIBO), which is more common in psoriasis patients, may help reduce skin inflammation.<\/li>\n<li>A fiber-rich diet supporting short-chain fatty acid (SCFA) production (butyrate, in particular) helps maintain gut barrier integrity.<\/li>\n<\/ul>\n<p style=\"font-size: 14px; color: #6b7280;\"><span style=\"background: #dbeafe; color: #1e40af; padding: 2px 8px; border-radius: 4px; font-weight: 600;\">Evidence: Emerging<\/span> Gut microbiome modulation for psoriasis is promising but still early. Larger, well-designed trials are needed.<\/p>\n<h3>Anti-Inflammatory Diet<\/h3>\n<p>No single diet cures psoriasis. But dietary patterns that reduce systemic inflammation consistently correlate with better outcomes.<\/p>\n<p><strong>The Mediterranean diet<\/strong> has the strongest evidence. A 2018 study in <em>JAMA Dermatology<\/em> found that greater adherence to a Mediterranean diet was associated with lower psoriasis severity. This diet emphasizes:<\/p>\n<ul>\n<li>Fatty fish (salmon, sardines, mackerel) 2-3 times per week<\/li>\n<li>Abundant vegetables, fruits, nuts, and legumes<\/li>\n<li>Olive oil as the primary fat source<\/li>\n<li>Limited red meat, processed foods, and refined sugar<\/li>\n<\/ul>\n<p><strong>Gluten:<\/strong> There is a well-documented connection between psoriasis and celiac disease. About 14% of psoriasis patients have elevated anti-gliadin antibodies, even without celiac disease. In these individuals, a gluten-free diet has shown measurable improvements. For psoriasis patients without gluten sensitivity markers, a gluten-free diet is unlikely to help.<\/p>\n<p><strong>Alcohol:<\/strong> Alcohol intake is consistently linked to worse psoriasis severity, poorer treatment response, and increased mortality. It disrupts the gut barrier, increases TNF-alpha, and can interfere with methotrexate and other medications.<\/p>\n<p><strong>Weight loss:<\/strong> Obesity is both a risk factor for developing psoriasis and a driver of disease severity. Fat tissue produces inflammatory cytokines (TNF-alpha, IL-6). A randomized trial showed that a low-calorie diet leading to 5-10% weight loss significantly improved PASI scores in overweight patients, independent of other treatments.<\/p>\n<p style=\"font-size: 14px; color: #6b7280;\"><span style=\"background: #dcfce7; color: #166534; padding: 2px 8px; border-radius: 4px; font-weight: 600;\">Evidence: Moderate to Strong<\/span> Mediterranean diet, weight loss in obese patients, and alcohol reduction all have good evidence supporting their role in psoriasis management.<\/p>\n<h3>Vitamin D Optimization<\/h3>\n<p>Vitamin D plays a central role in immune regulation and skin cell differentiation. It is no coincidence that topical vitamin D analogs are a mainstay of psoriasis treatment. But what about systemic vitamin D levels?<\/p>\n<p>Multiple studies have found that psoriasis patients have significantly lower serum 25-hydroxyvitamin D levels compared to healthy controls. A 2013 meta-analysis confirmed this association across multiple populations.<\/p>\n<p><strong>Practical approach:<\/strong><\/p>\n<ul>\n<li>Get your 25-OH vitamin D level tested. Most functional medicine practitioners target 40-60 ng\/mL (100-150 nmol\/L), which is higher than the standard &#8220;sufficient&#8221; cutoff of 30 ng\/mL.<\/li>\n<li>Supplementation with vitamin D3 (cholecalciferol) at 2,000-5,000 IU daily is common; some patients need more based on lab values.<\/li>\n<li>Pair with vitamin K2 (MK-7 form) to support proper calcium metabolism.<\/li>\n<li>Sensible sun exposure (10-15 minutes on large skin areas before applying sunscreen) provides both vitamin D and direct anti-inflammatory benefits via UV-induced immunomodulation.<\/li>\n<\/ul>\n<p style=\"font-size: 14px; color: #6b7280;\"><span style=\"background: #dbeafe; color: #1e40af; padding: 2px 8px; border-radius: 4px; font-weight: 600;\">Evidence: Moderate<\/span> Low vitamin D is associated with psoriasis, but supplementation trials have shown mixed results. Optimization is reasonable as part of a broader strategy.<\/p>\n<h3>Fish Oil (Omega-3 Fatty Acids)<\/h3>\n<p>Omega-3 fatty acids (EPA and DHA) from fish oil compete with arachidonic acid in inflammatory pathways, reducing the production of pro-inflammatory prostaglandins and leukotrienes.<\/p>\n<p>A 2014 meta-analysis of 12 randomized controlled trials found a modest but statistically significant benefit of fish oil supplementation for psoriasis, particularly at doses of 2-3 grams of combined EPA\/DHA daily. The effect was more pronounced in patients also receiving conventional treatment, suggesting a synergistic benefit.<\/p>\n<p>The best approach is to combine supplementation with dietary omega-3 sources (fatty fish, walnuts, flaxseed) while reducing omega-6-heavy seed oils that promote inflammation.<\/p>\n<p style=\"font-size: 14px; color: #6b7280;\"><span style=\"background: #dbeafe; color: #1e40af; padding: 2px 8px; border-radius: 4px; font-weight: 600;\">Evidence: Moderate<\/span> Modest benefit as adjunctive therapy. Not a standalone treatment, but a reasonable addition.<\/p>\n<h3>Curcumin (Turmeric Extract)<\/h3>\n<p>Curcumin is one of the most studied natural anti-inflammatory compounds. It inhibits NF-kB, a master regulator of inflammatory gene expression, and suppresses TNF-alpha, IL-17, and other cytokines involved in psoriasis.<\/p>\n<p>A 2019 randomized, double-blind, placebo-controlled trial published in <em>BioMed Research International<\/em> found that oral curcumin supplementation (2 grams daily of a bioavailable formulation) significantly reduced PASI scores compared to placebo over 12 weeks. Topical curcumin formulations have also shown benefit in smaller studies.<\/p>\n<p>The challenge with curcumin is bioavailability. Standard turmeric powder is poorly absorbed. Look for formulations using piperine (black pepper extract), phospholipid complexes (Meriva), or nanoparticle technology to improve absorption.<\/p>\n<p style=\"font-size: 14px; color: #6b7280;\"><span style=\"background: #dbeafe; color: #1e40af; padding: 2px 8px; border-radius: 4px; font-weight: 600;\">Evidence: Emerging to Moderate<\/span> Promising results in clinical trials, but more large-scale studies are needed. Bioavailable formulations are essential.<\/p>\n<h3>Stress Management<\/h3>\n<p>Stress is not just a trigger for psoriasis flares. It creates a vicious cycle: psoriasis causes stress, and stress worsens psoriasis. The mechanism involves the hypothalamic-pituitary-adrenal (HPA) axis and the release of cortisol and neuropeptides that directly promote skin inflammation.<\/p>\n<p>Studies on mind-body interventions for psoriasis have shown real results:<\/p>\n<ul>\n<li><strong>Mindfulness-Based Stress Reduction (MBSR):<\/strong> A landmark study by Jon Kabat-Zinn showed that psoriasis patients who listened to mindfulness meditation tapes during UVB phototherapy cleared 4x faster than those receiving phototherapy alone.<\/li>\n<li><strong>Cognitive Behavioral Therapy (CBT):<\/strong> Multiple trials show that CBT reduces psoriasis severity, improves quality of life, and helps patients adhere to treatment plans.<\/li>\n<li><strong>Regular exercise:<\/strong> Reduces inflammatory markers (CRP, IL-6) and helps with weight management. Aim for 150+ minutes of moderate activity per week.<\/li>\n<\/ul>\n<p style=\"font-size: 14px; color: #6b7280;\"><span style=\"background: #dcfce7; color: #166534; padding: 2px 8px; border-radius: 4px; font-weight: 600;\">Evidence: Strong<\/span> Stress management improves psoriasis outcomes. This is well-established across multiple study types.<\/p>\n<h3>Red Light Therapy (Photobiomodulation)<\/h3>\n<p>Red light therapy (630-660 nm) and near-infrared light (810-850 nm) are gaining attention for their anti-inflammatory and tissue-healing properties. Unlike UV light, these wavelengths do not carry skin cancer risk.<\/p>\n<p>The proposed mechanisms include stimulation of mitochondrial cytochrome c oxidase, increased ATP production, reduced oxidative stress, and modulation of NF-kB signaling. Several small studies and case series have shown improvements in plaque thickness, redness, and scaling with red\/NIR light therapy.<\/p>\n<p>A 2019 pilot study found that combination blue (415 nm) and red (633 nm) LED therapy significantly reduced PASI scores in mild-to-moderate plaque psoriasis over 12 weeks. While not a replacement for NB-UVB phototherapy in severe disease, red light therapy offers a low-risk option worth exploring, particularly for localized or mild cases.<\/p>\n<p style=\"font-size: 14px; color: #6b7280;\"><span style=\"background: #fef3c7; color: #92400e; padding: 2px 8px; border-radius: 4px; font-weight: 600;\">Evidence: Emerging<\/span> Promising early data. More rigorous trials needed before definitive conclusions can be drawn.<\/p>\n<h2>Psoriasis Comorbidities: Why This Is More Than a Skin Disease<\/h2>\n<p>If you take one thing from this article, let it be this: psoriasis is a systemic inflammatory disease that affects your entire body. The same inflammatory pathways driving your skin lesions are quietly affecting other organ systems.<\/p>\n<h3>Cardiovascular Disease<\/h3>\n<p>Patients with severe psoriasis have a 50% increased risk of cardiovascular events (heart attack, stroke) compared to the general population. Psoriasis accelerates atherosclerosis through chronic systemic inflammation. Young patients with severe psoriasis lose an estimated 5-6 years of life expectancy, primarily due to cardiovascular mortality. Recent studies suggest that effective treatment of psoriasis with biologics may reduce this cardiovascular risk.<\/p>\n<h3>Metabolic Syndrome<\/h3>\n<p>Psoriasis patients are significantly more likely to develop metabolic syndrome: the combination of obesity, insulin resistance, high blood pressure, and abnormal lipids. The relationship is bidirectional. Inflammation drives metabolic dysfunction, and metabolic dysfunction amplifies inflammation. Screening for blood sugar, lipids, and blood pressure should be routine in all psoriasis patients.<\/p>\n<h3>Depression and Mental Health<\/h3>\n<p>Depression occurs in approximately 25-30% of psoriasis patients, which is 1.5 to 2 times the rate in the general population. The stigma of visible skin disease, chronic itch, sleep disruption, and the neuroinflammatory effects of systemic cytokines all contribute. Suicidal ideation is more common in psoriasis patients than many people realize, particularly in those with severe disease. Mental health screening should be part of routine psoriasis care.<\/p>\n<h3>Other Associated Conditions<\/h3>\n<ul>\n<li><strong>Non-alcoholic fatty liver disease (NAFLD):<\/strong> More prevalent in psoriasis, especially in patients on methotrexate<\/li>\n<li><strong>Inflammatory bowel disease (Crohn&#8217;s, ulcerative colitis):<\/strong> Shares genetic and immunologic pathways with psoriasis<\/li>\n<li><strong>Type 2 diabetes:<\/strong> Risk is elevated by ~50% in severe psoriasis<\/li>\n<li><strong>Chronic kidney disease:<\/strong> Increasingly recognized association, particularly in severe disease<\/li>\n<li><strong>Uveitis and other eye conditions:<\/strong> Inflammatory eye disease can accompany psoriatic arthritis<\/li>\n<\/ul>\n<div style=\"background: #fffbeb; border-left: 4px solid #f59e0b; border-radius: 8px; padding: 20px 24px; margin: 24px 0;\">\n<strong style=\"color: #92400e;\">Key Takeaway:<\/strong> If you have psoriasis, ask your doctor about cardiovascular risk screening, metabolic labs (fasting glucose, HbA1c, lipid panel), and mental health assessment. These should be part of your regular care, not afterthoughts.\n<\/div>\n<h2>Dermatologist vs. Rheumatologist: Who Should You See?<\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 24px 0; border-radius: 8px; overflow: hidden;\">\n<thead>\n<tr style=\"background: #1e3a5f; color: #ffffff;\">\n<th style=\"padding: 14px 18px; text-align: left;\">See a Dermatologist If&#8230;<\/th>\n<th style=\"padding: 14px 18px; text-align: left;\">See a Rheumatologist If&#8230;<\/th>\n<th style=\"padding: 14px 18px; text-align: left;\">See Both If&#8230;<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Your primary concern is skin disease<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">You have joint pain, stiffness, or swelling<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">You have both significant skin involvement AND joint symptoms<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">You need diagnosis of your skin condition<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">You have &#8220;sausage digits&#8221; (dactylitis)<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">You are on a biologic that needs monitoring for both conditions<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Topicals and phototherapy are sufficient for your care<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">You have lower back or sacroiliac pain, especially with morning stiffness<\/td>\n<td style=\"padding: 12px 18px; border-bottom: 1px solid #e2e8f0;\">Treatment decisions require coordinated expertise<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 12px 18px;\">You need ongoing skin monitoring and management<\/td>\n<td style=\"padding: 12px 18px;\">Enthesitis (tendon\/ligament pain at bone attachments) is present<\/td>\n<td style=\"padding: 12px 18px;\">Your current treatment is not adequately controlling both skin and joint disease<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The ideal scenario for patients with psoriatic arthritis is co-management between a dermatologist and a rheumatologist. Many academic medical centers now have combined psoriasis-PsA clinics for exactly this reason.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<div style=\"margin: 32px 0;\">\n<div style=\"border: 1px solid #e2e8f0; border-radius: 8px; padding: 20px 24px; margin-bottom: 16px;\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Is psoriasis contagious?<\/h3>\n<p>No. Psoriasis is not contagious in any way. You cannot catch it from touching someone&#8217;s skin, sharing towels, or any other form of contact. It is an immune-mediated condition with genetic roots. This is one of the most persistent myths about the disease, and it contributes to unnecessary stigma.<\/p>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; border-radius: 8px; padding: 20px 24px; margin-bottom: 16px;\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Can psoriasis be cured?<\/h3>\n<p>There is currently no cure for psoriasis. However, it can be very effectively managed. With modern biologic therapies, many patients achieve near-complete or complete skin clearance (PASI 90 or PASI 100). Some patients on IL-23 inhibitors have maintained clear skin even after stopping treatment, raising hopes that long-term drug-free remission may be possible for some people. Research is ongoing.<\/p>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; border-radius: 8px; padding: 20px 24px; margin-bottom: 16px;\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">What is the difference between psoriasis and eczema?<\/h3>\n<p>Both cause red, inflamed skin, but they differ in key ways. Psoriasis typically produces well-defined, thick, silvery-scaled plaques on extensor surfaces (outside of elbows and knees). Eczema (atopic dermatitis) tends to appear in flexural areas (inside of elbows and knees), with thinner, weeping, or crusty patches. Psoriasis is driven by Th17 cells; eczema is primarily a Th2-mediated condition. They also respond to different treatments. A dermatologist can usually distinguish between them on visual examination.<\/p>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; border-radius: 8px; padding: 20px 24px; margin-bottom: 16px;\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Are biologics safe for long-term use?<\/h3>\n<p>The safety data for biologics in psoriasis is now extensive, with some agents having 15+ years of real-world follow-up. Overall, they are well-tolerated. The main risks include increased susceptibility to infections (particularly upper respiratory infections) and, in rare cases, reactivation of latent tuberculosis (which is why TB screening is required before starting treatment). There is no consistent evidence of increased cancer risk with most biologics. Your dermatologist will monitor you with regular check-ups and lab work. For most patients, the benefits of controlling severe psoriasis far outweigh the risks.<\/p>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; border-radius: 8px; padding: 20px 24px; margin-bottom: 16px;\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Does diet really affect psoriasis?<\/h3>\n<p>Yes, but the effect varies by individual. The strongest dietary evidence supports weight loss in overweight patients, adherence to a Mediterranean-style diet, and alcohol reduction. Gluten-free diets may help the subset of patients with anti-gliadin antibodies. Broadly, reducing processed foods, sugar, and seed oils while increasing omega-3s, fiber, and antioxidant-rich foods tends to lower systemic inflammation. Diet alone will not replace medical treatment for moderate-to-severe disease, but it can meaningfully improve outcomes alongside conventional therapy.<\/p>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; border-radius: 8px; padding: 20px 24px; margin-bottom: 16px;\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">How do I know if I am developing psoriatic arthritis?<\/h3>\n<p>Early warning signs include morning stiffness lasting more than 30 minutes, swollen and tender joints (especially in fingers and toes), pain in the heel or sole of the foot (enthesitis), lower back stiffness, and reduced range of motion. Nail changes (pitting, ridging, separation from nail bed) in psoriasis patients are a strong predictor of future PsA development. If you notice any of these symptoms, see a rheumatologist promptly. Early treatment prevents permanent joint damage.<\/p>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; border-radius: 8px; padding: 20px 24px; margin-bottom: 16px;\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Can children get psoriasis?<\/h3>\n<p>Yes. About one-third of psoriasis cases begin in childhood. Guttate psoriasis is especially common in children, often appearing after a strep throat infection. Pediatric psoriasis can present differently than adult disease, and treatment options are somewhat more limited due to safety considerations with systemic medications. However, several biologics are now approved for pediatric use, and topical therapies remain the first line for most children.<\/p>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; border-radius: 8px; padding: 20px 24px; margin-bottom: 16px;\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Is psoriasis linked to heart disease?<\/h3>\n<p>Yes, and this connection is significant. Severe psoriasis is considered an independent risk factor for cardiovascular disease, similar to diabetes. Chronic systemic inflammation accelerates atherosclerosis (plaque buildup in arteries). Patients with severe psoriasis have a higher risk of heart attack, stroke, and cardiovascular death. This risk is highest in young patients with severe disease. All psoriasis patients should have regular cardiovascular risk assessments, including blood pressure, cholesterol, and blood sugar monitoring.<\/p>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; border-radius: 8px; padding: 20px 24px; margin-bottom: 16px;\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">What about pregnancy and psoriasis?<\/h3>\n<p>Many women experience improvement in their psoriasis during pregnancy, likely due to the natural immune shifts that occur (a shift from Th1\/Th17 toward Th2 dominance). However, some women experience worsening, and postpartum flares are common. Treatment options become more limited during pregnancy. Topical steroids (low-to-mid potency) and UVB phototherapy are considered safe. Most systemic medications and biologics require careful risk-benefit discussions. Methotrexate and acitretin are absolutely contraindicated during pregnancy. Certolizumab (Cimzia) is sometimes considered as it has minimal placental transfer. Planning ahead with your dermatologist before conception is the best approach.<\/p>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; border-radius: 8px; padding: 20px 24px; margin-bottom: 16px;\">\n<h3 style=\"color: #1e40af; margin-top: 0;\">Can functional medicine approaches replace conventional treatment?<\/h3>\n<p>For mild psoriasis, some patients do achieve adequate control through diet, stress management, supplements, and lifestyle changes alone. For moderate-to-severe disease, functional medicine approaches work best as complements to conventional therapy, not replacements. Think of it as building a strong foundation: optimize your gut health, vitamin D levels, diet, and stress management, and your conventional treatments will likely work better, at potentially lower doses. The goal is an integrative approach where both sides of medicine work together.<\/p>\n<\/div>\n<\/div>\n<h2>Building Your Psoriasis Management Plan<\/h2>\n<p>The best outcomes in psoriasis come from combining evidence-based medical treatment with lifestyle and functional medicine strategies. Here is a practical framework:<\/p>\n<ol>\n<li><strong>Get properly diagnosed and staged.<\/strong> Know your type of psoriasis, your PASI\/BSA score, and whether you have any joint involvement. This shapes everything that follows.<\/li>\n<li><strong>Work with the right specialist(s).<\/strong> A dermatologist for skin-predominant disease. Add a rheumatologist if joints are involved. Consider a functional medicine practitioner for the lifestyle optimization piece.<\/li>\n<li><strong>Build your treatment plan from the ground up.<\/strong> Start with the foundation (diet, weight management, stress reduction, vitamin D, sleep) and layer on the appropriate medical treatments.<\/li>\n<li><strong>Screen for comorbidities.<\/strong> Get your cardiovascular risk factors checked. Talk about your mental health. Monitor for signs of psoriatic arthritis.<\/li>\n<li><strong>Be patient, but not passive.<\/strong> Psoriasis treatment often involves trial and adjustment. If something is not working after an adequate trial (typically 12-16 weeks for biologics), speak up. There are many options available today.<\/li>\n<li><strong>Track your progress.<\/strong> Take photos, note your triggers, and track flares. This data is valuable for you and your treatment team.<\/li>\n<\/ol>\n<p>Psoriasis is a condition that science understands far better than it did even a decade ago. The treatment options available today, from advanced biologics to gut health strategies to red light therapy, give patients more paths to clear or near-clear skin than ever before. The key is approaching it as the whole-body condition it truly is and building a management plan that addresses inflammation from every angle.<\/p>\n<p style=\"background: linear-gradient(135deg, #f0f9ff 0%, #e8f4f8 100%); border-radius: 12px; padding: 24px 28px; margin-top: 40px; font-size: 15px; color: #334155;\"><strong>Medical Disclaimer:<\/strong> This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before making changes to your treatment plan. If you are experiencing a psoriasis flare or new symptoms, contact your dermatologist.<\/p>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Related Reading<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"\/blog\/arthritis-guide\/\">Arthritis Guide: Rheumatoid Arthritis and Osteoarthritis<\/a><\/li><li><a href=\"\/blog\/celiac-disease\/\">Celiac Disease<\/a><\/li><li><a href=\"\/blog\/crohns-disease\/\">Crohn&#8217;s Disease<\/a><\/li><li><a href=\"\/blog\/eczema\/\">Eczema (Atopic Dermatitis): Types, Triggers, Treatments, and the Functional Medicine Approach<\/a><\/li><li><a href=\"\/blog\/ehlers-danlos-syndrome-diagnosis\/\">Ehlers-Danlos Syndrome: Diagnostic Criteria, Types, and What the 2026 Updates Mean for You<\/a><\/li><li><a href=\"\/blog\/joint-pain\/\">Joint Pain: Causes, Diagnosis, and the Full Treatment Spectrum<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Psoriasis at a Glance Affects: ~125 million people worldwide (~3% of the global population) Type: Chronic, immune-mediated inflammatory skin disease Most common form: Plaque psoriasis (80-90% of cases) Key driver: Overactive T-cells accelerate skin cell turnover from ~28 days to 3-4 days Genetic link: Over 80 gene loci identified; 30-40% of patients have a first-degree&#8230;<\/p>\n","protected":false},"author":1,"featured_media":6215,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_regenerated_references":"","footnotes":""},"categories":[1009],"tags":[],"class_list":["post-5196","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-skin-conditions"],"_links":{"self":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/comments?post=5196"}],"version-history":[{"count":2,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5196\/revisions"}],"predecessor-version":[{"id":5491,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5196\/revisions\/5491"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media\/6215"}],"wp:attachment":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media?parent=5196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/categories?post=5196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/tags?post=5196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}